Ultrasound-Guided Interfascial Hydrodissection for Gluteal Myofascial Pain in Piriformis Syndrome: A Prospective Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorIstanbul University - Cerrahpasa

About this trial

This randomized, double-blind prospective trial investigates whether ultrasound-guided interfascial hydrodissection using 10% dextrose is more effective than dry needling in treating gluteal myofascial pain coexisting with piriformis syndrome. Following diagnostic piriformis injection response, eligible patients will be randomized into two treatment arms and followed at 1 hour, 1 week, 1 month, and 3 months. The primary hypothesis is that interfascial hydrodissection will provide superior long-term analgesic outcomes due to fascial separation, neuromodulation, and nociceptor suppression.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 to 75 years

Buttock pain with or without radiation to the lower extremity

Ability to understand and provide written informed consent

Disqualifiers

Active lumbar radiculopathy

History of hip joint pathology or prior hip surgery

Previous injection or dry needling treatment to the gluteal region within the last 3 months

Coagulation disorders or use of anticoagulant therapy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ultrasound-Guided Interfascial Hydrodissection

    Procedure/Surgery

    Ultrasound-guided interfascial hydrodissection is performed in the interfascial plane between the gluteus maximus and piriformis muscles.

  • Ultrasound-Guided Gluteus Maximus Dry Needling

    Procedure/Surgery

    Ultrasound-guided dry needling is performed on the gluteus maximus muscle without fluid administration.

Treatment groups

42 Participants
are divided into 2 treatment groups
Group A: Ultrasound-Guided Interfascial HydrodissectionExperimental treatment 1 intervention
Group B: Ultrasound-guided gluteus maximus dry needlingActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain Intensity Assessed by Numeric Rating Scale

Pain intensity is assessed using the Numeric Rating Scale (NRS, 0-10) for pain at rest, during activity, at night, while standing, sitting, lying down, and for overall pain.

Time frame
3 months after the intervention

Secondary outcomes

1

Pain Intensity Assessed by Numeric Rating Scale

Pain intensity is assessed using the Numeric Rating Scale (NRS, 0-10) for pain at rest, during activity, at night, while standing, sitting, lying down, and for overall pain.

Time frame
1 week after the intervention
2

Pain Intensity Assessed by Numeric Rating Scale

Pain intensity is assessed using the Numeric Rating Scale (NRS, 0-10) for pain at rest, during activity, at night, while standing, sitting, lying down, and for overall pain.

Time frame
1 month after the intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: